Department of Pathology Microbiology and Immunology

September 20, 2018

Santoro to step down as department chair of PMI

After serving as the department’s leader for more than 15 years, Samuel A. Santoro, MD, PhD, the Dorothy B. and Theodore R. Austin Professor and Chair of the Department of Pathology, Microbiology and Immunology, will step down from his role as the department’s chair after the completion of a national search to identify his successor.

By John Howser
September 13, 2018

Healthy antibodies reverse diabetes

Vanderbilt researchers have discovered that IgM-type antibodies appear to play a protective role to prevent the development of type 1 diabetes — and that purified IgM antibodies can reverse the disease.

By Leigh MacMillan
September 13, 2018

Research reveals link between immunity, diabetes

When it comes to diet-induced obesity, your immune system is not always your friend.

By Bill Snyder
September 6, 2018

Link between immune system, disease explored

The first Flexner Discovery Lecture of the academic year featured presentations by two Vanderbilt faculty members.

By Leigh MacMillan
August 23, 2018

Madhur, Smith set to deliver fall season’s first Discovery Lecture

The Flexner Discovery Lecture series kicks off the academic year next week with presentations by two Vanderbilt faculty members. The Cutting-Edge Discovery Lectures by Meena Madhur, MD, PhD, and Scott Smith, MD, PhD, begin at 4 p.m. on Thursday, Aug. 30 in 208 Light Hall.

By Leigh MacMillan
August 2, 2018

Connecting an asthma gene to leukemia

A receptor previously implicated in asthma may also play roles in other allergic diseases and in leukemia, Vanderbilt researchers have discovered.

By Leigh MacMillan
July 19, 2018

Team finds potent antibodies against three Ebola viruses

Researchers at Vanderbilt University Medical Center and their colleagues are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans.
By Bill Snyder
July 19, 2018

VUMC Diagnostic Laboratories expand, improve services

Vanderbilt University Medical Center’s Diagnostic Laboratories continue to expand in-house services in order to more efficiently diagnose and treat patients. A recent survey indicates clinicians’ overall satisfaction with the efforts.
By Jill Clendening
June 28, 2018

New staph virulence factor

Jun. 28, 2018—The new factor, an enzyme involved in host-pathogen interactions, may be a viable target for treating staph infections.
By Leigh MacMillan
June 14, 2018

Karijolich named 2018 Pew Biomedical Scholar

John Karijolich, PhD, assistant professor of Pathology, Microbiology, and Immunology at Vanderbilt University Medical Center, has been named a Pew Biomedical Scholar by The Pew Charitable Trusts.
By Leigh MacMillan
June 8, 2018

A “public” target for HIV

Common sequences of antibodies against HIV may be key to developing a successful vaccine strategy for the virus.
By Bill Snyder
May 21, 2018

New target to stop Ebola

A new Vanderbilt study suggests it may be possible to develop antibody therapies or a universal vaccine effective against multiple Ebola virus family members.
By VUMC News and Communications
May 17, 2018

Alphavirus “Achilles heel”

Targeting the protein that mosquito-borne viruses use to enter cells could be a strategy for preventing infection by multiple emerging viruses.
By Bill Snyder